Corbus Pharmaceuticals Holdings, Inc. Insider Trading
CRBP
Insiders bought 126K and sold 629K on the open market.
84% of the selling was scheduled in advance under 10b5-1 plans.
Get an email when CRBP's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Oct 29 | Cormorant Asset Management, LP Large holder | SoldNo plan | 425,000 | $4.10 | $1.74M | 18% | Form 4 |
| Sep 14 | Yong Ben Director | Sold10b5-1 plan | 2,000 | $7.84 | 16K | 18% | Form 4 |
| Aug 11 | Nishant C Saxena Chief Business Officer | Bought | 2,600 | $9.63 | 25K | 3.5% | Form 4 |
| Aug 7 | Yuval Cohen Chief Executive Officer | Sold10b5-1 plan | 17,000 | $10.08 | 171K | 9.8% | Form 4 |
| Aug 7 | Sean F. Moran Chief Financial Officer | Sold10b5-1 plan | 12,000 | $10.08 | 121K | 12% | Form 4 |
| Jun 10 | Winston Kung Director | Sold10b5-1 plan | 2,026 | $7.91 | 16K | 14% | Form 4 |
| Jun 10 | John Kenneth Jenkins Director | Sold10b5-1 plan | 4,800 | $7.91 | 38K | 56% | Form 4 |
| Jun 10 | Anne Altmeyer Director | Sold10b5-1 plan | 2,412 | $7.91 | 19K | 24% | Form 4 |
| Jun 2 – 3 | Nishant C Saxena Chief Business Officer | Bought 2 parts | 13,500 | $7.50 average | 101K | 22% | Form 4 |
| Mar 2 | Dominic Smethurst Chief Medical Officer | SoldNo plan | 6,097 | $8.30 | 51K | 6.4% | Form 4 |
| Feb 17 | Ian Hodgson Chief Operating Officer | SoldNo plan | 847 | $7.38 | 6K | 1.6% | Form 4 |
| Feb 13 | Sean F. Moran Chief Financial Officer | Sold10b5-1 plan | 4,701 | $7.78 | 37K | 4.6% | Form 4 |
| Feb 13 | Yuval Cohen Chief Executive Officer | Sold10b5-1 plan | 13,871 | $7.78 | 108K | 7.4% | Form 4 |
| Feb 3 | Dominic Smethurst Chief Medical Officer | SoldNo plan | 3,285 | $8.09 | 27K | 3.3% | Form 4 |
| Feb 3 | Ian Hodgson Chief Operating Officer | SoldNo plan | 2,415 | $8.09 | 20K | 4.4% | Form 4 |
| Dec 11, 2025 | Bihua Chen Large holder | SoldNo plan | 30,029 | $11.46 | 344K | 1.3% | Form 4 |
| Oct 24, 2025 – Oct 27, 2025 | Yuval Cohen Chief Executive Officer | Sold10b5-1 plan 2 parts | 27,633 | $17.05 average | 471K | 17% | Form 4 |
| Oct 24, 2025 | Sean F. Moran Chief Financial Officer | Sold10b5-1 plan | 12,981 | $17.02 | 221K | 15% | Form 4 |
| Oct 20, 2025 | Anne Altmeyer Director | Sold10b5-1 plan | 1,060 | $20.50 | 22K | 15% | Form 4 |
| May 30, 2025 | John Kenneth Jenkins Director | Sold10b5-1 plan | 2,783 | $7.35 | 20K | 37% | Form 4 |
| May 30, 2025 | Anne Altmeyer Director | Sold10b5-1 plan | 1,392 | $7.25 | 10K | 18% | Form 4 |
| Mar 6, 2025 | Dominic Smethurst Chief Medical Officer | SoldNo plan | 6,393 | $6.78 | 43K | 8.3% | Form 4 |
| Feb 14, 2025 | Sean F. Moran Chief Financial Officer | Sold10b5-1 plan | 2,792 | $8.76 | 24K | 3.7% | Form 4 |
| Feb 14, 2025 | Yuval Cohen Chief Executive Officer | Sold10b5-1 plan | 7,134 | $8.76 | 62K | 4.9% | Form 4 |
- Oct 29No planCormorant Asset Management, LPLarge holder · sold 425,000 at $4.10$1.74M18% of stake
- Sep 1410b5-1 planYong BenDirector · sold 2,000 at $7.8416K18% of stake
- Aug 11Nishant C SaxenaChief Business Officer · bought 2,600 at $9.6325K3.5% of stake
- Aug 710b5-1 planYuval CohenChief Executive Officer · sold 17,000 at $10.08171K9.8% of stake
- Aug 710b5-1 planSean F. MoranChief Financial Officer · sold 12,000 at $10.08121K12% of stake
- Jun 1010b5-1 planWinston KungDirector · sold 2,026 at $7.9116K14% of stake
- Jun 1010b5-1 planJohn Kenneth JenkinsDirector · sold 4,800 at $7.9138K56% of stake
- Jun 1010b5-1 planAnne AltmeyerDirector · sold 2,412 at $7.9119K24% of stake
- Jun 2 – 3Nishant C SaxenaChief Business Officer · bought 13,500 at avg $7.50101K22% of stake
- Mar 2No planDominic SmethurstChief Medical Officer · sold 6,097 at $8.3051K6.4% of stake
- Feb 17No planIan HodgsonChief Operating Officer · sold 847 at $7.386K1.6% of stake
- Feb 1310b5-1 planSean F. MoranChief Financial Officer · sold 4,701 at $7.7837K4.6% of stake
- Feb 1310b5-1 planYuval CohenChief Executive Officer · sold 13,871 at $7.78108K7.4% of stake
- Feb 3No planDominic SmethurstChief Medical Officer · sold 3,285 at $8.0927K3.3% of stake
- Feb 3No planIan HodgsonChief Operating Officer · sold 2,415 at $8.0920K4.4% of stake
- Dec 11, 2025No planBihua ChenLarge holder · sold 30,029 at $11.46344K1.3% of stake
- Oct 24, 2025 – Oct 27, 202510b5-1 planYuval CohenChief Executive Officer · sold 27,633 at avg $17.05471K17% of stake
- Oct 24, 202510b5-1 planSean F. MoranChief Financial Officer · sold 12,981 at $17.02221K15% of stake
- Oct 20, 202510b5-1 planAnne AltmeyerDirector · sold 1,060 at $20.5022K15% of stake
- May 30, 202510b5-1 planJohn Kenneth JenkinsDirector · sold 2,783 at $7.3520K37% of stake
- May 30, 202510b5-1 planAnne AltmeyerDirector · sold 1,392 at $7.2510K18% of stake
- Mar 6, 2025No planDominic SmethurstChief Medical Officer · sold 6,393 at $6.7843K8.3% of stake
- Feb 14, 202510b5-1 planSean F. MoranChief Financial Officer · sold 2,792 at $8.7624K3.7% of stake
- Feb 14, 202510b5-1 planYuval CohenChief Executive Officer · sold 7,134 at $8.7662K4.9% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with CRBP
Held by ETFs
CRBP is in 1 US ETF. The largest of them, with CRBP's weight in each:
Spot a number that looks wrong? Check it in CRBP's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing CRBP
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.